Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company ...

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

CVRx (Nasdaq:CVRX) shares took a hit today on fourth-quarter results that fell short of earnings per share expectations.

Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for CVRx in a research report issued on Wednesday, ...

At the heart of Archer-Daniels-Midland's operations ... Looking ahead, ADM is projecting an EPS range of $4.00 to $4.75 for 2025, reflecting an optimistic yet cautious forecast amid anticipated ...

NVO's fourth-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, especially ...

With Episode 4 dropping on Thursday evening, Cotton teased shooting the episode was “heart-stopping” for the EPs, recalling “I thought we’d have a heart attack.” Below, Cotton and Rees ...

the heart of our concern, being what steps council is taking to address conflicts that arise," she said. "And then also … ensuring that we can say both to the members of EPS and to the public ...

Conflicted Jason Kelce Reveals Who He'll Root for in Eagles-Chiefs Super Bowl RFK Jr: I've prayed daily for 20-years that God 'would put me in a position' to end chronic disease I'm a heart surgeon.